Retatrutide is a new medication in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By boosting these https://delilahdyrz277198.ageeksblog.com/35014119/tirzepatide-a-promising-new-treatment-for-obesity